Advertisement

Topics

BioLogic Company Company Profile

02:53 EDT 25th September 2017 | BioPortfolio

BioLogic grows, formulates, and sells, natural insect parasites and pathogens of pests. Our natural biocontrol products for horticulture, home, lawn, garden, and greenhouse kill insect pests, but are more specific and therefore safer than many other controls. As safe pesticides, they can be allowed to persist longer than many chemicals. With their modes of action, there is less risk for pest insect populations to develop resistance.
This site will help you decide if our natural pesticide controls (beneficial nematodes, ladybugs, praying mantises, etc.) can help you and expedite ordering, shipment, and quick delivery. It also serves as a brief reference about BioLogic Company

Location

P.O. Box 177
Willow Hill
Pennsylvania
17271
United States of America

Contact

Phone: (717)349-2789
Email: sales@biologicco.com


News Articles [461 Associated News Articles listed on BioPortfolio]

China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London

BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the ...

China Biologic Products to Report Second Quarter of 2017 Financial Results

BEIJING, July 19, 2017 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China...

China Biologic Products to Report Second Quarter 2012 Financial Results

BEIJING, August 3, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutica...

China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)

BEIJING, May 7, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the ...

Samsung Bioepis and Takeda Collaborate for Development of Multiple Novel Biologic Therapies

INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. announced today that it has entered into a strategic collaboration agreement with Takeda Pharmaceutical Company Limited (TSE: 4502)...

Insurance type linked with biologic treatment for patients with RA

Among patients with rheumatoid arthritis, insurance type as well as race, previous steroid use and non-biologic disease-modifying antirheumatic drug use were linked with initial or subsequent treatmen...

Study of oral biologic tackles peanut allergies

Aimmune Therapeutics is testing an oral biologic, AR101, as a peanut protein desensitizing agent.  -More- 

Australia considering biologic-naming conventions

Australia's Therapeutic Goods Administration is seeking public comment on a naming system for biologic and biosimilar product -More- 

PubMed Articles [208 Associated PubMed Articles listed on BioPortfolio]

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.

This study assessed the occurrence of indicators for suboptimal biologic therapy among ulcerative colitis (UC) and Crohn's disease (CD) patients over time in the United States (US). Data from a large ...

Patterns of Care for Biologic-Dosing Outliers and Nonoutliers in Biologic-Naive Patients with Rheumatoid Arthritis.

Although most biologic medications for patients with rheumatoid arthritis (RA) have recommended fixed dosing, actual biologic dosing may vary among real-world patients, since some patients can receive...

Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

Systemic biologic and nonbiologic agents used to treat psoriasis may or may not contribute to serious infection (SI) risk. Safety data, particularly for biologic agents, and associated risk for SI, ar...

Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study.

Although biologics are important inflammatory bowel disease therapies, loss of response (LOR) remains problematic. We evaluated LOR to biologics in our Crohn disease (CD) patients receiving biologics....

Patient Preference for Dosing Frequency Based on Prior Biologic Experience.

There is limited research exploring patient preferences regarding dosing frequency of biologic treatment of psoriasis.

Clinical Trials [466 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

This study is designed to analyze the frequency and incidence rate of pulmonary complications in JIA participants who received biological DMARDs and non-biologic DMARDs. The participants h...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

That anti-TNF therapy and rituximab therapy are equally effective in treating patients with rheumatoid arthritis who meet the eligibility criteria for biologic therapy in the British Socie...

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction

To date, there have been no prospective randomized controlled trials that compare various biologic mesh materials in the context of abdominal wall reconstruction. As a result, this proposa...

Companies [1466 Associated Companies listed on BioPortfolio]

China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and...

BioLogic Company

BioLogic grows, formulates, and sells, natural insect parasites and pathogens of pests. Our natural biocontrol products for horticulture, home, lawn, garden, and greenhouse kill insect pests, but are ...

Nanotherapeutics, Inc.

Nanotherapeutics, Inc. is a privately held biopharmaceutical company. Its product pipeline includes, an FDA-approved injectable biologic product (OrigenTM DBM, marketing partner O...

Osteotech, Inc.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing biologic solutions for regenerative medicine to support surgeons and their patients in the repair of the muscul...

Biologic GmbH & Co KG

Biologic beschäftigt sich mit der Entwicklung von biotechnologischen Produkten und Verfahren für den Umweltschutz bis zur technischen Marktreife mit entsprechendem Marketingkonzept. Nach erwiesener ...

More Information about "BioLogic Company" on BioPortfolio

We have published hundreds of BioLogic Company news stories on BioPortfolio along with dozens of BioLogic Company Clinical Trials and PubMed Articles about BioLogic Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLogic Company Companies in our database. You can also find out about relevant BioLogic Company Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record